Dàta Tuarastail H-1B

Dachaigh › Luchd-obrach › Vertex Pharmaceuticals Incorporated › Gene Editing Senior Research Scientist

Gene Editing Senior Research Scientist aig Vertex Pharmaceuticals Incorporated: Tuarastalan H-1B

5 iarrtasan cumhaichean-obrach airson an dreuchd Gene Editing Senior Research Scientist aig Vertex Pharmaceuticals Incorporated. Tuarastal bunasach meadhanach $124,842; leth meadhanach $124,842–$125,342.

Iarrtasan (LCAs)5
Tuarastal meadhanach a chaidh a thabhann$124,842
Leath mheadhanach nan tuarastalan$124,842–$125,342
Ceudail 10mh–90mh$122,867–$127,425

A rèir bliadhna ionmhais

Bliadhna mhaoineLCAsTuarastal meadhanach
FY20241$125,342
FY20253$124,842
FY20261$128,814

Iarrtasan

Tuarastal bunasachÀiteAir a chur a-steachCeann-latha tòiseachaidhInbhe
$128,814–$189,500
Ìre III
Boston, MA26 Gearr 202627 Gearr 2026Dearbhaichte
$124,842–$163,605
Ìre IV
Boston, MA25 Gearr 202519 Lùna 2025Dearbhaichte
$124,842–$163,416
Ìre IV
Boston, MA24 Gearr 202518 Lùna 2025Dearbhaichte
$121,550–$164,450
Ìre II
Boston, MA7 Samh 20246 Faoi 2025Dearbhaichte
$125,342–$169,581
Ìre II
Boston, MA14 Màrt 20243 Lùna 2024Dearbhaichte

Obraichean eile aig Vertex Pharmaceuticals Incorporated

Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).